Eurofarma chosen the second best company in remuneration in São Paulo and, the best in its area of business, as well
Published in: March 1, 2017
and updated in: November 4, 2021
Listen to the text
Stop the audio
Eurofarma was acknowledged as the second company with most satisfied collaborators when it comes to remuneration and benefits in São Paulo and also as the best in its area of business, indicated survey by portal Love Mondays.
The company obtained 4.57 average grade (with 5 as the maximum grade) and won the second general position, behind Credit Suisse alone, which obtained average of 4.91.
In order to participate in the ranking, companies should have, at least, 20 assessments in the last 12 months, have office in São Paulo and be above the general average in the subject.
Check below the Ranking with the 10 first positions.
About Eurofarma Group
Eurofarma Group is the first Brazilian multinational pharmaceutical with 100% national capital. Acknowledged by the medical community and society for promoting access to health and quality of life with treatments at fair prices, with quality and innovation, is present in 20 countries.
With 45 years of existence and 6,500 collaborators, its position is outstanding in the segments where it operates: Medical Prescription and Over-the-counter, Generic, Hospital, Biddings, Oncology, and Services to Third Parties. Its portfolio comprises over 280 products and, in 2016, over 290 million units of medication were produced. Last year, the Group reached income of R$ 3.3 billion, 15.7% higher than in the previous year.
In 2016, with R$ 141 million in investments and its expertise and agility in Research and Development, it became the pharmaceutical with best performance in portfolio renovation, counting, today, on 176 projects in the pipeline.
For further information, access www.eurofarma.com.br
Information to Press
G&A Public Relations – Clareane Moraes | (11) 3065-3045 | clareane@gaspar.com.br Guilherme Gaspar | (11) 3065-3049 | guilherme@gaspar.com.br
The company obtained 4.57 average grade (with 5 as the maximum grade) and won the second general position, behind Credit Suisse alone, which obtained average of 4.91.
In order to participate in the ranking, companies should have, at least, 20 assessments in the last 12 months, have office in São Paulo and be above the general average in the subject.
Check below the Ranking with the 10 first positions.
About Eurofarma Group
Eurofarma Group is the first Brazilian multinational pharmaceutical with 100% national capital. Acknowledged by the medical community and society for promoting access to health and quality of life with treatments at fair prices, with quality and innovation, is present in 20 countries.
With 45 years of existence and 6,500 collaborators, its position is outstanding in the segments where it operates: Medical Prescription and Over-the-counter, Generic, Hospital, Biddings, Oncology, and Services to Third Parties. Its portfolio comprises over 280 products and, in 2016, over 290 million units of medication were produced. Last year, the Group reached income of R$ 3.3 billion, 15.7% higher than in the previous year.
In 2016, with R$ 141 million in investments and its expertise and agility in Research and Development, it became the pharmaceutical with best performance in portfolio renovation, counting, today, on 176 projects in the pipeline.
For further information, access www.eurofarma.com.br
Information to Press
G&A Public Relations – Clareane Moraes | (11) 3065-3045 | clareane@gaspar.com.br Guilherme Gaspar | (11) 3065-3049 | guilherme@gaspar.com.br